Maci 3CM x 5CM implant sheets
Ended Awarded Last action
- Contract number
- SPE2DR26FCZC3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,176
Award facts
- Contract value 100% obligated
- $63,175.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $63,175.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, operates under firm fixed-price terms with no set-aside designation. DMS Pharmaceutical Group is performing this work at its Park Ridge facility and will deliver the specialty surgical implant product to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract (SPE2DR), a single-award contract valued at $499.999 billion awarded on November 13, 2025, with completion through December 31, 2036. The PPV-G GEN V represents DLA's comprehensive pharmaceutical supply initiative, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to provide branded and generic pharmaceuticals, biologics, medical consumables, and specialty surgical products to military healthcare facilities worldwide. The company has demonstrated substantial federal contracting activity through DLA's Medical Supply Chain division and maintains no identified subcontractor relationships on this award.
Quick answers
Who was awarded contract SPE2DR26FCZC3?
SPE2DR26FCZC3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FCZC3 worth?
The government has obligated $63,176 on SPE2DR26FCZC3.
Is contract SPE2DR26FCZC3 an order under another contract?
Yes. SPE2DR26FCZC3 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZC3 competed?
The extent of competition for SPE2DR26FCZC3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award